Literature DB >> 999550

Long-term epinephrine therapy of ocular hypertension.

D H Shin, A E Kolker, M A Kass, M B Kaback, B Becker.   

Abstract

Nineteen patients with symmetrical ocular hypertension and symmetrical cupping of the optic nerves were made asymmetric with respect to intraocular pressure for one to five years by unilateral topical treatment with epinephrine hydrochloride. Development of glaucomatous visual field defects was observed in 32% of the untreated eyes and in none of the treated eyes (P less than .05). Progressive cupping of the optic nerve was noted in 53% of the untreated eyes and in 11% of the treated eyes (P less than .025). Evidence of glaucomatous damage was observed more frequently in subjects maintained on this regimen for longer periods and in subjects with initial horizontal cup/disc ratios greater than 0.4 (P less than .05). None of the eyes, either treated or untreated, with mean intraocular pressures less than 24 mm Hg developed glaucomatous damage during the period of this study.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 999550     DOI: 10.1001/archopht.1976.03910040719002

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Changing concepts of primary open-angle glaucoma and early detection.

Authors:  R N Battista; P Huston; M W Davis
Journal:  Can Fam Physician       Date:  1986-07       Impact factor: 3.275

Review 2.  Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials.

Authors:  Philip C Maier; Jens Funk; Guido Schwarzer; Gerd Antes; Yngve T Falck-Ytter
Journal:  BMJ       Date:  2005-07-01

3.  Periodic health examination, 1995 update: 3. Screening for visual problems among elderly patients. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1995-04-15       Impact factor: 8.262

Review 4.  Treating ocular hypertension to reduce glaucoma risk: when to treat?

Authors:  Eve J Higginbotham
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Does medical treatment of mild intraocular hypertension prevent glaucoma?

Authors:  I Aguinaga Ontoso; F Guillen Grima; E Aguinaga Ontoso; L R Fernandez Fernandez
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

6.  Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.

Authors:  M A Kass
Journal:  Trans Am Ophthalmol Soc       Date:  1989

7.  Epinephrine distribution after topical administration to phakic and aphakic eyes.

Authors:  S G Kramer
Journal:  Trans Am Ophthalmol Soc       Date:  1980

8.  Medical outcomes of glaucoma therapy from a nationwide representative survey.

Authors:  Philippe Denis; Antoine Lafuma; Gilles Berdeaux
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

9.  Effect of IOP on the visual field in ocuLar hypertension and glaucoma.

Authors:  A Heijl
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.